Efficacy of MP1032 in hospitalised patients with COVID-19- authors' reply
Petra Sager1, Astrid Kaiser1, Sara Schumann1
1MetrioPharm Deutschland GmbH, Am Borsigturm 100, 13507, Berlin, Germany.
The Lancet Regional Health. Europe
|February 8, 2024
Abstract
No abstract available in PubMed .
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
517
05:46A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
4.9K
Related Concept Videos
01:28Pneumonia IV: Management
327
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
01:30Pneumonia III: Complications and Assessment
219
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
219